Cargando…

The construction of a hypoxia-based signature identified CA12 as a risk gene affecting uveal melanoma cell malignant phenotypes and immune checkpoint expression

Uveal melanoma (UM) is a deadly intraocular neoplasm in the adult population and harbors limited therapeutic effects from the current treatment. Here, we aimed to investigate the role of hypoxia in UM progress. We adopted the Cancer Genome Atlas data set as a training cohort and Gene Expression Omni...

Descripción completa

Detalles Bibliográficos
Autores principales: Yin, Yan, Du, Wei, Li, Fei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9548707/
https://www.ncbi.nlm.nih.gov/pubmed/36226072
http://dx.doi.org/10.3389/fonc.2022.1008770
_version_ 1784805491611795456
author Yin, Yan
Du, Wei
Li, Fei
author_facet Yin, Yan
Du, Wei
Li, Fei
author_sort Yin, Yan
collection PubMed
description Uveal melanoma (UM) is a deadly intraocular neoplasm in the adult population and harbors limited therapeutic effects from the current treatment. Here, we aimed to investigate the role of hypoxia in UM progress. We adopted the Cancer Genome Atlas data set as a training cohort and Gene Expression Omnibus data sets as validating cohorts. We first used consensus clustering to identify hypoxia-related subtypes, and the C1 subtype predicted an unfavorable prognosis and exhibited high infiltration of immunocytes and globally elevated immune checkpoint expression. Besides this, the patients with the C1 subtype were predicted to respond to the PD-1 treatment. By the least absolute shrinkage and selection operator algorithm, we constructed a hypoxia risk score based on the hypoxia genes and identified 10 genes. The risk score predicted patient survival with high performance, and the high-risk group also harbored high immunocyte infiltration and immune checkpoint expression. Furthermore, we confirmed that the risk genes were upregulated under hypoxia, and knockdown of CA12 inhibited the epithelial–mesenchymal transition process, clone formation ability, and G1/S phase transformation of the UM cells. The CD276 was also downregulated when CA12 knockdown was performed. These results validate the prognostic role of the hypoxia signature in UM and demonstrate that CA12 is a critical factor for UM cell progression as well as a target to improve immunotherapeutic effects. We believe our study contributes to the understanding of hypoxia’s roles in UM and provides a novel target that will benefit future therapeutic strategy development.
format Online
Article
Text
id pubmed-9548707
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-95487072022-10-11 The construction of a hypoxia-based signature identified CA12 as a risk gene affecting uveal melanoma cell malignant phenotypes and immune checkpoint expression Yin, Yan Du, Wei Li, Fei Front Oncol Oncology Uveal melanoma (UM) is a deadly intraocular neoplasm in the adult population and harbors limited therapeutic effects from the current treatment. Here, we aimed to investigate the role of hypoxia in UM progress. We adopted the Cancer Genome Atlas data set as a training cohort and Gene Expression Omnibus data sets as validating cohorts. We first used consensus clustering to identify hypoxia-related subtypes, and the C1 subtype predicted an unfavorable prognosis and exhibited high infiltration of immunocytes and globally elevated immune checkpoint expression. Besides this, the patients with the C1 subtype were predicted to respond to the PD-1 treatment. By the least absolute shrinkage and selection operator algorithm, we constructed a hypoxia risk score based on the hypoxia genes and identified 10 genes. The risk score predicted patient survival with high performance, and the high-risk group also harbored high immunocyte infiltration and immune checkpoint expression. Furthermore, we confirmed that the risk genes were upregulated under hypoxia, and knockdown of CA12 inhibited the epithelial–mesenchymal transition process, clone formation ability, and G1/S phase transformation of the UM cells. The CD276 was also downregulated when CA12 knockdown was performed. These results validate the prognostic role of the hypoxia signature in UM and demonstrate that CA12 is a critical factor for UM cell progression as well as a target to improve immunotherapeutic effects. We believe our study contributes to the understanding of hypoxia’s roles in UM and provides a novel target that will benefit future therapeutic strategy development. Frontiers Media S.A. 2022-09-26 /pmc/articles/PMC9548707/ /pubmed/36226072 http://dx.doi.org/10.3389/fonc.2022.1008770 Text en Copyright © 2022 Yin, Du and Li https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Yin, Yan
Du, Wei
Li, Fei
The construction of a hypoxia-based signature identified CA12 as a risk gene affecting uveal melanoma cell malignant phenotypes and immune checkpoint expression
title The construction of a hypoxia-based signature identified CA12 as a risk gene affecting uveal melanoma cell malignant phenotypes and immune checkpoint expression
title_full The construction of a hypoxia-based signature identified CA12 as a risk gene affecting uveal melanoma cell malignant phenotypes and immune checkpoint expression
title_fullStr The construction of a hypoxia-based signature identified CA12 as a risk gene affecting uveal melanoma cell malignant phenotypes and immune checkpoint expression
title_full_unstemmed The construction of a hypoxia-based signature identified CA12 as a risk gene affecting uveal melanoma cell malignant phenotypes and immune checkpoint expression
title_short The construction of a hypoxia-based signature identified CA12 as a risk gene affecting uveal melanoma cell malignant phenotypes and immune checkpoint expression
title_sort construction of a hypoxia-based signature identified ca12 as a risk gene affecting uveal melanoma cell malignant phenotypes and immune checkpoint expression
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9548707/
https://www.ncbi.nlm.nih.gov/pubmed/36226072
http://dx.doi.org/10.3389/fonc.2022.1008770
work_keys_str_mv AT yinyan theconstructionofahypoxiabasedsignatureidentifiedca12asariskgeneaffectinguvealmelanomacellmalignantphenotypesandimmunecheckpointexpression
AT duwei theconstructionofahypoxiabasedsignatureidentifiedca12asariskgeneaffectinguvealmelanomacellmalignantphenotypesandimmunecheckpointexpression
AT lifei theconstructionofahypoxiabasedsignatureidentifiedca12asariskgeneaffectinguvealmelanomacellmalignantphenotypesandimmunecheckpointexpression
AT yinyan constructionofahypoxiabasedsignatureidentifiedca12asariskgeneaffectinguvealmelanomacellmalignantphenotypesandimmunecheckpointexpression
AT duwei constructionofahypoxiabasedsignatureidentifiedca12asariskgeneaffectinguvealmelanomacellmalignantphenotypesandimmunecheckpointexpression
AT lifei constructionofahypoxiabasedsignatureidentifiedca12asariskgeneaffectinguvealmelanomacellmalignantphenotypesandimmunecheckpointexpression